5 Health Trends To Read Up On In 2023

As the healthcare industry continues to expand and evolve, staying up-to-date on trends is vital. Staying informed can help you make better decisions when it comes to your health as well as the care of those around you. Keep reading about which healthcare trends you should know more about in 2023.

Dietary Supplements

Dietary supplements are becoming increasingly popular among those looking for an easy way to get all their essential vitamins and minerals without drastically changing their diet or lifestyle habits. Accessories offer an easy way for people who may not have access to healthy foods (or who may not have time) to get all the nutrients they need in one convenient package – no cooking required.

Aside from supplements, devices such as the HELO Air Caffeine Pen will likely become more popular. However, it’s essential to research before taking any supplement because some can interact with medications you may already be taking or have other side effects if taken incorrectly (or too much).

Telemedicine

Telemedicine has rapidly grown into a popular trend within healthcare during the pandemic. Patients can receive medical care through virtual telephone calls, video chats, and other web-based technologies. This trend is only projected to continue as it provides both patients and providers with great convenience when making medical appointments and increased accessibility.

Specifically, telemedicine can be employed effectively for remote diagnosis, follow-up visits, mental health services, networking, and even primary care treatment plans. Moreover, it offers an alternate but ideal way to provide utility in patient/provider interviews. It accurately keeps pace with present-day reality risk reduction practices in medicine by obeying ‘social distancing.’

Data-Driven Care

Data-driven care is also becoming increasingly prevalent in the healthcare industry. Data-driven care uses big data analytics to provide personalized treatment plans tailored to each patient’s unique needs and circumstances. This technology allows providers to understand each individual’s health needs better and create more effective treatments based on this information.

Data-driven care also helps improve patient outcomes by monitoring vitals and other medical indicators so providers can quickly detect changes or abnormalities in a patient’s condition and take appropriate action if necessary.

Patient Engagement Technologies

Another significant trend in healthcare is patient engagement technologies such as wearables and mobile apps that allow patients to track their health data over time or connect with their providers remotely. These tools help empower patients by giving them access to their health information which they can then share with their doctors or nurses. Additionally, they provide an easy way for patients to stay connected with their providers between appointments or check-ins without leaving home.

The Rise Of AI In Healthcare

Artificial intelligence (AI) has become increasingly prevalent in healthcare settings in recent years, and this trend is expected to continue into 2023. AI can automate tedious tasks such as data entry, allowing healthcare providers more time to focus on patient care. It also helps doctors diagnose illnesses faster by giving them access to an ever-growing medical information database.

AI-enabled diagnostics typically involves using machine learning algorithms or deep learning techniques to analyze large amounts of medical data quickly and accurately identify patterns or anomalies that could indicate certain conditions or diseases before they develop further down the line.

Conclusion

With so many exciting advances happening within the healthcare space right now, it’s easy to see why these trends—dietary supplements, telemedicine, data-driven care, patient engagement technologies, and the rise of AI in healthcare—are set to become even more popular over the next few years ahead. Devices like the HELO Air Caffeine Pen may be relatively new now, but they have the potential to become commonplace in 2023 and beyond.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”